Viberzi FDA Approval History
Viberzi (eluxadoline) is a mu-opioid receptor agonist indicated for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.
Development Timeline for Viberzi
|May 27, 2015||FDA Approves Viberzi (eluxadoline) for Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults|
|Sep 2, 2014||Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.